BioNTech
Advancing science to help transform cancer and infectious disease treatments
Healthcare & MedicalFree
About BioNTech
BioNTech operates a diversified mRNA pipeline including oncology candidates using lipid nanoparticles. It shares mRNA roots with Kernal but emphasizes personalized neoantigen vaccines over in vivo CAR-T selectivity. Larger scale and approved products give it commercial reach Kernal currently lacks.
What BioNTech does
BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases. The company focuses on translating fundamental research into therapies that harness the immune system, with priority programs spanning adjuvant and advanced cancer settings plus infectious disease applications. It maintains a pipeline of over 25 Phase 2 and Phase 3 oncology trials and invests heavily in R&D to advance combination approaches.
Key features
- mRNA cancer immunotherapies
- BNT327 bispecific PD-L1/VEGF-A antibody
- 25+ mid-to-late stage oncology trials
- Combination therapy strategy
- Infectious disease mRNA vaccine programs
- €2.1 bn annual R&D investment
Pricing
Free
Similar Products
Therapy for Black Girls
Culturally responsive mental health resources and therapist directory for Black women and girls.
Healthcare & MedicalFree
Manhattan Mental Health Counseling
NYC-based online therapy with licensed therapists accepting insurance for anxiety, trauma, and life transitions.
Healthcare & MedicalFree
T
Teen Counseling
Online therapy for teens and parents via text, phone, and video from licensed therapists.
Healthcare & MedicalFree